Follow the 大幸薬品株式会社 stock price and the full management transaction log of the company, a listed equity based in Japan. Shares trade on JP JP, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 大幸薬品株式会社 has published 11 insider filings. Market capitalisation: €12.7bn. The latest transaction was reported on 20 October 2023 (Holding update). Among the most active insiders: Nomura Securities Co.,Ltd.. Every trade is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Daiichi Pharmaceutical Co., Ltd. is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the Tokyo Stock Exchange under the symbol XTKS.